Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Le Tourneau

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Bulletin Du Cancer|January 12, 2011
[Dose finding methods for targeted agents: new perspectives]X Paoletti, S Postel-Vinay, V Servois, et al.
Annales De Biologie Clinique|June 26, 2004
[ABO incompatibility and newborn haemolytic disease: two cases with major erythroblastosis]S Palleau, C Le Tourneau, I Jrad, et al.
ESMO Open|January 3, 2022
Impact of the timing of tumor assessments on median progression-free survival in clinical trials in advanced cancer patientsT Samaille, C Moreau Bachelard, E Coquan, et al.
Biotechnology Reports (Amsterdam, Netherlands)|November 18, 2020
Review of clinical applications of radiation-enhancing nanoparticlesN Scher, S Bonvalot, C Le Tourneau, et al.
ESMO Open|March 6, 2021
Intrapatient comparisons of efficacy in a single-arm trial of entrectinib in tumour-agnostic indicationsM G Krebs, J-Y Blay, C Le Tourneau, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 7, 2022
Efficacy and Tolerance of Carboplatin plus Cetuximab (Simplified EXTREME Regimen) in Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell CarcinomaC Le Roy, D Vernerey, C Evin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 19, 2019
Novel patterns of response under immunotherapyE Borcoman, Y Kanjanapan, S Champiat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2015
Designs of preoperative biomarkers trials in oncology: a systematic review of the literatureM Marous, I Bièche, X Paoletti, et al.
Bulletin Du Cancer|April 10, 2009
[Prognosis factors of cholangiocarcinoma: contribution of recent molecular biology tools]G Malouf, C Dreyer, N Guedj, et al.
European Journal of Cancer Care|October 14, 2016
Patients' perceived tolerance of side effects in phase I cancer clinical trials: A qualitative studyA Brédart, S Bodson, C Le Tourneau, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Bulletin Du Cancer|January 12, 2011
[Dose finding methods for targeted agents: new perspectives]X Paoletti, S Postel-Vinay, V Servois, et al.
Annales De Biologie Clinique|June 26, 2004
[ABO incompatibility and newborn haemolytic disease: two cases with major erythroblastosis]S Palleau, C Le Tourneau, I Jrad, et al.
ESMO Open|January 3, 2022
Impact of the timing of tumor assessments on median progression-free survival in clinical trials in advanced cancer patientsT Samaille, C Moreau Bachelard, E Coquan, et al.
Biotechnology Reports (Amsterdam, Netherlands)|November 18, 2020
Review of clinical applications of radiation-enhancing nanoparticlesN Scher, S Bonvalot, C Le Tourneau, et al.
ESMO Open|March 6, 2021
Intrapatient comparisons of efficacy in a single-arm trial of entrectinib in tumour-agnostic indicationsM G Krebs, J-Y Blay, C Le Tourneau, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 7, 2022
Efficacy and Tolerance of Carboplatin plus Cetuximab (Simplified EXTREME Regimen) in Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell CarcinomaC Le Roy, D Vernerey, C Evin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 19, 2019
Novel patterns of response under immunotherapyE Borcoman, Y Kanjanapan, S Champiat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2015
Designs of preoperative biomarkers trials in oncology: a systematic review of the literatureM Marous, I Bièche, X Paoletti, et al.
Bulletin Du Cancer|April 10, 2009
[Prognosis factors of cholangiocarcinoma: contribution of recent molecular biology tools]G Malouf, C Dreyer, N Guedj, et al.
European Journal of Cancer Care|October 14, 2016
Patients' perceived tolerance of side effects in phase I cancer clinical trials: A qualitative studyA Brédart, S Bodson, C Le Tourneau, et al.
Pageof 6